Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.
Front Med (Lausanne). 2020 Jun 30;7:303. doi: 10.3389/fmed.2020.00303. eCollection 2020.
Front Med (Lausanne). 2020.
PMID: 32695790
Free PMC article.
Review.